New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 13, 2012
07:23 EDTCYTKCytokinetics has potentially transformative catalysts, says JMP Securities
After attending Cytokinetics' R&D day, JMP Securities believes that the company has multiple value-inflecting and potentially transformative catalysts in 2013. The firm thinks the company may obtain a partner for its tirasemtiv treatment, and JMP Securities reiterates an Outperform rating on the shares.
News For CYTK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2015
10:18 EDTCYTKCytokinetics management to meet with JMP Securities
Subscribe for More Information
July 29, 2015
16:07 EDTCYTKCytokinetics sees FY15 reven, consensus $28.55M
16:06 EDTCYTKCytokinetics reports Q2 EPS (27c), consensus (24c)
Reports Q2 revenue $6.54M, consensus $7.32M. Reports cash, cash equivalents, and investments $108.2M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use